EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Loganin, an Iridoid Glycoside, Alleviates Paclitaxel‐Induced Skeletal Muscle Toxicity by Enhancing Mitochondrial Function, Boosting Antioxidant Defenses, and Reducing Cellular Senescence

Yu-Fan Chuang, Cai-Rong Wu, Wan-Hsuan Chang, Ying-Jung Su, Hung-Te Hsu, Fan-Li Lin iD, Yi-Ching Lo iD

The Kaohsiung Journal of Medical Sciences · 2025

DOI: 10.1002/kjm2.70117 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Kaohsiung Journal of Medical Sciences, 2025. Verfasst von Yu-Fan Chuang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, School of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan. Hauptthemen laut MEDLINE: Cellular Senescence, Muscle, Skeletal, Paclitaxel, Antioxidants. Die Arbeit nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Science and Technology Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Mitochondrial dysfunction and energy imbalance caused by chemotherapy are key contributors to skeletal muscle atrophy, which severely impacts the quality of life in cancer patients. Paclitaxel, a commonly used chemotherapeutic agent, is known to promote muscle wasting and cellular senescence, largely by impairing mitochondrial function. In this study, we investigated the protective role of loganin, a naturally occurring iridoid glycoside, in preventing paclitaxel‐induced damage to skeletal muscle cells. Using C2C12 cells, we assessed whether loganin could counteract the harmful effects of paclitaxel. Our results demonstrated that loganin significantly improved cell viability and protected mitochondrial function, as reflected by better preservation of mitochondrial DNA content, membrane potential, and ATP production, while further enhancing mitochondrial biogenesis through upregulation of PGC‐1α, TFAM, and NRF1. In parallel, loganin activated metabolic regulators SIRT1 and AMPK, while restoring PDK4 expression, suggesting improved energy regulation. Additionally, glycogen levels and myotube morphology were maintained, alongside sustained myosin heavy chain expression. Loganin effectively reduced both cellular and mitochondrial reactive oxygen species and increased antioxidant defenses, including superoxide dismutase activity and glutathione levels. Notably, it also suppressed paclitaxel‐induced senescence and inflammation, as shown by decreased p21 expression, reduced NFκB phosphorylation, and lower levels of Cdkn1a and Il6 as well as reduced SA‐β‐gal staining. Overall, our findings demonstrate that loganin offers comprehensive protection against paclitaxel‐induced skeletal muscle injury by preserving mitochondrial function, supporting metabolic homeostasis, reducing oxidative stress, and limiting senescence. These results highlight the potential of loganin as a preventive adjunctive agent to mitigate chemotherapy‐related muscle toxicity.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cellular SenescenceMuscle, SkeletalPaclitaxelAntioxidantsMitochondriaIridoidsAnimalsMiceCell LineReactive Oxygen SpeciesCell SurvivalOxidative StressSirtuin 1Membrane Potential, Mitochondrial

Stichwörter der Autor:innen

cellular senescenceloganinmitochondrial dysfunctionpaclitaxel‐induced myotoxicityskeletal muscle atrophy

Substanzen

PaclitaxelAntioxidantsIridoidsloganinReactive Oxygen SpeciesSirtuin 1

Autor:innen und Institutionen

  • Department of Pharmacology, School of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan.
  • Graduate Institute of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan.
  • Department of Anesthesiology, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan.
  • Department of Anesthesiology, School of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan.
  • School of Post-Baccalaureate Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan.
  • Department of Medical Research, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan.

ORCID-Profile: Fan-Li Lin, Yi-Ching Lo

Förderung

  • National Science and Technology Council

Zitieren

APA

Chuang, Y. F., Wu, C. R., Chang, W. H., Su, Y. J., Hsu, H. T., Lin, F. L., & Lo, Y. C. (2025). Loganin, an Iridoid Glycoside, Alleviates Paclitaxel‐Induced Skeletal Muscle Toxicity by Enhancing Mitochondrial Function, Boosting Antioxidant Defenses, and Reducing Cellular Senescence. The Kaohsiung Journal of Medical Sciences. https://doi.org/10.1002/kjm2.70117

Vancouver

Chuang YF, Wu CR, Chang WH, Su YJ, Hsu HT, Lin FL, et al. Loganin, an Iridoid Glycoside, Alleviates Paclitaxel‐Induced Skeletal Muscle Toxicity by Enhancing Mitochondrial Function, Boosting Antioxidant Defenses, and Reducing Cellular Senescence. The Kaohsiung Journal of Medical Sciences. 2025. doi:10.1002/kjm2.70117

BibTeX
@article{Chuang2025,
  author = {Chuang, Yu-Fan and Wu, Cai-Rong and Chang, Wan-Hsuan and Su, Ying-Jung and Hsu, Hung-Te and Lin, Fan-Li and Lo, Yi-Ching},
  title = {Loganin, an Iridoid Glycoside, Alleviates Paclitaxel‐Induced Skeletal Muscle Toxicity by Enhancing Mitochondrial Function, Boosting Antioxidant Defenses, and Reducing Cellular Senescence},
  journal = {The Kaohsiung Journal of Medical Sciences},
  year = {2025},
  doi = {10.1002/kjm2.70117}
}
Kostenlos starten →